Pancreatic ductal adenocarcinoma (PDAC) is associated with metaplastic changes in the 3 pancreas but the transcriptional program underlying these changes is incompletely understood. 4
Introduction
1 Pancreatic ductal adenocarcinoma (PDAC) is the most common malignancy in pancreas and 2 the third leading cause of cancer-related deaths in US 1 . Emerging evidence suggests that 3 pancreatic acinar cells can acquire ductal cell-like characteristics and down-regulate genes 4 maintaining acinar cell identify, also known as acinar-to-ductal metaplasia (ADM). This process 5 is reversible because once the injury is resolved the acinar-cell-derived ductal-like cells can 6 revert back to acinar cells 2, 3 . However, in the presence of additional stresses, such as a Kras G12D 7 mutation, ADM cannot be reversed and cells are "locked" into a transdifferentiated state before 8 converting to precancerous pancreatic intraepithelial neoplasia (PanIN) lesions and subsequently 9 invasive PDAC 4-6 . In mice, pancreatic tumorigenesis is dramatically hastened by the presence of 10 pancreatitis 7, 8 , while, in humans, induction of chronic inflammation is a common character in 11 many known risk factors for pancreatic cancer including diabetes, pancreatitis, alcohol 12 consumption and tobacco use 9 . However, the complete transcriptional program that regulates the 13 interconversion of acinar cells to ductal-like cells and vice versa, and the role of these events in 14 the context of tumorigenesis are still unclear. 15 PRDM3 is a nuclear transcription factor involved in many biological processes including 16 hematopoiesis, development, cell differentiation and apoptosis 10 . PRDM3 belongs to the positive 17 regulatory domain (PRDM) family proteins, which are characterized by an N-terminal PR 18 (PRDI-BF1-RIZ1 homologous) domain followed by an array of C2H2 zinc finger motifs for 19 sequence-specific DNA binding and a C-terminal binding protein (CtBP)-binding domain for 20 protein-protein interactions 11 . PRDM3 is necessary for the maintenance of hematopoietic stem 21 cells 12, 13 . A recent study has reported that PRDM3 is weakly expressed in normal pancreatic 22 acinar cells and upregulated in many PDAC precursor lesions and PDAC 14 . Using siRNA-23 mediated knockdown of PRDM3 in PK-8 pancreatic cancer cells, Tanaka and colleagues also 1 showed that PRDM3 promotes pancreatic cancer cell proliferation and migration through the 2 inhibition of a KRAS suppressor miR-96 14 . Despite this characterization of the effects of 3 PRDM3 inhibition in pancreatic tumor cells ex vivo, the role of PRDM3 during tumor initiation 4 from acinar cells in vivo is unclear. 5
Here, we used a CreER-inducible mouse model to genetically delete Prdm3 specifically in 6 adult acinar cells to examine the functional role of PRDM3 in pancreatic carcinogenesis. Our 7 results show that Prdm3 deficiency potentiates inflammation, promotes tumour initiation and 8 dramatically accelerates malignant progression, which is consistent with our findings indicating 9 that PRDM3 loss is significantly associated with poorer survival in patients with PDAC. We 10 further demonstrate that PRDM3 is important to suppress the expression of genes involved in 11 inflammatory response in pancreatic acinar cells. These findings suggest an inhibitory role of 12 PRDM3 in pancreatic tumorigenesis. Future development of drugs that target PRDM3 might yield 13 novel approaches to benefit the treatment of PDAC. 14 15
Results

16
PRDM3 is upregulated in pancreatitis as well as well-differentiated PDAC and its high 17 expression is associated with better survival in patients with PDAC 18 We first characterized the expression of PRDM3 and its relevance to pancreatic cancer 19 prognosis by analyzing a cohort of 94 patients who were diagnosed with PDAC and received 20 surgical resection without preoperative chemotherapy. We found that PRDM3 was strongly 21 expressed in precancerous PanIN lesions ( Fig. 1c-c' ) and well-differentiated PDAC from 22 patients ( Fig. 1d-d') , while moderately to poorly differentiated cancer cells showed little to no 23 staining of PRDM3 ( Fig. 1e -e' and f-f', Table 1 ). Our observation of heterogeneous expression 1 of PRDM3 in PDAC was supported by recent study demonstrating that PRDM3 is selectively 2 expressed in low-grade PDAC cells featured differentiated epithelia, but not high-grade cells 3 showed fibroblastoid morphology 15 . We performed subsequent overall survival and disease-free 4 survival analyses with these 94 PDAC patients and found that patients with high levels of 5 PRDM3 lived significantly longer than those with low levels of PRDM3 (Overall survival: 16.03 6 months vs 9.33 months; Disease-free survival: 12.37 months vs 7.4 months) ( Fig. 1g ). Our 7 clinical relevance analysis clearly revealed that a better survival in patient with PDAC was 8 associated with high levels of PRDM3 expression, but not with age, gender, tumor size, location, 9 TNM (tumour-node-metastasis), or CA19-9 ( Table 1) . Given that pancreatitis is a well-described 10 risk factor for PDAC development, we also analyzed pancreatic tissue from 22 patients with 11 chronic pancreatitis. We found a dramatically increase of PRDM3 protein levels in inflamed 12 tissues compared with normal pancreas (Fig. 1a -a' and b-b'; Supplementary Table 1) . 13
Similarly, administration of supraphysiologic concentrations of a cholecystokinin ortholog, 14 cerulein, in mice resulted in acute pancreatitis and Prdm3 upregulation in murine acinar cells 15 ( Supplementary Fig. 1a ). Consistent with findings from previous reports 14 , we also observed 16 strong expression of Prdm3 in the precursor lesions of PDAC including ADM, low-grade PanINs, 17 and high-grade PanINs found in pancreata from mice expressing oncogenic Kras in pancreatic 18 acinar cells (Ptf1a CreER ;Kras G12D ) ( Supplementary Fig. 1b) . Together, our results demonstrated 19 that elevated levels of PRDM3 are associated with inflamed pancreatic epithelia and well-20 differentiated pancreatic lesions, while low levels of PRDM3 are associated with poorly 21 differentiated carcinoma and a worse prognostic outcome in patients with PDAC. 22
Ablation of Prdm3 enhances Kras G12D -stimulated PDAC initiation and progression 1
To determine whether Prdm3 is functionally important for pancreatic carcinogenesis in vivo, 2 we applied a genetic strategy to induce expression of oncogenic Kras G12D and deletion of Prdm3 3 in adult acinar cells, simultaneously. Cre-mediated recombination was induced in pancreatic 4 acinar cells using the tamoxifen-inducible Ptf1a CreER allele 16 . The Mds1 and Evi1 complex locus 5 (Mecom) encodes a full-length isoform of Prdm3, and a shorter isoform lacking the N-terminus 6 PR domain. We therefore used a Prdm3 flox mouse which harbors two LoxP sites flanking exon 4, 7 the first shared exon in the long-and short-isoform of Prdm3 12 , to completely eliminate Prdm3 8 in pancreatic acinar cells upon tamoxifen induced recombination. By combining the Kras LSL-G12D 9 allele 17 with the Ptf1a CreER allele with/without the Prdm3 flox allele, we generated control 10 Ptf1a CreER ;Kras G12D (Kras G12D ) mice, as well as Ptf1a CreER ;Kras G12D ;Prdm3 flox/flox (Kras G12D -11
Prdm3 ΔAcinar ) mice ( Supplementary Fig. 2a ). 12
To initiate recombination, we injected mice with tamoxifen at 4 to 5 weeks of age and 13 analyzed pancreata at 4-and 6-weeks post-injection ( Fig. 2a ). Comparison of Prdm3 expression 14 in Kras G12D -Prdm3 ΔAcinar and Kras G12D mice after tamoxifen administration showed an almost 15 complete loss of Prdm3 protein in Kras G12D -Prdm3 ΔAcinar acinar cells ( Supplementary Fig. 2b) . 16
Four weeks after tamoxifen-mediated recombination, small areas of ADM and occasional low-17 grade PanINs were observed in the control Kras G12D mice. In contrast, Kras G12D -Prdm3 ΔAcinar 18 mice, with loss of Prdm3 proteins in pancreatic acinar cells, exhibited more cuboidal to columnar 19 duct-like structures with enlarged lumens ( Supplementary Fig. 2c ). Quantification of the 20 number of PanINs revealed that preneoplastic lesions arising in Kras G12D -Prdm3 ΔAcinar mice 21 increased significantly compared to Kras G12D mice (Fig. 2b ). More intriguingly, we observed 4 22 out of 5 Kras G12D -Prdm3 ΔAcinar mice developed high-grade PanINs at 4 weeks post-tamoxifen 23 injection ( Fig. 2c) , while no high-grade lesions were found in Kras G12D mice even at 3 months of 1 age (data not shown). Consistent with these findings, at 6 weeks post-tamoxifen injection 2 Kras G12D -Prdm3 ΔAcinar mice exhibited higher number of lesions with histological and molecular 3 characteristics of PanINs indicated by the expression of Cytokeratin 19 (CK19) and Mucin 5AC 4 (Muc5AC) (Fig. 2d ). Together, these data suggest that deletion of Prdm3 promotes ADM and 5
PanIN formation in the presence of oncogenic Kras expression. 6
We next examined whether loss of Prdm3 promotes neoplastic progression. To accelerate 7 the formation of invasive lesions, we induced cerulein-mediated acute pancreatitis in cooperation 8 with acinar-cell-specific activation of oncogenic Kras as previously described 4 . One week after 9 tamoxifen administration, Kras G12D -Prdm3 ΔAcinar and Kras G12D mice were injected hourly with 50 10 μ g/kg cerulein over 6 hours on alternating days. The pancreata were harvested at 21 days post-11 cerulein injection (Fig. 3a) . Pancreata from Kras G12D -Prdm3 ΔAcinar mice had full spectrum of 12 precursor lesions including low-grade PanINs, high-grade PanINs and ductal carcinoma in situ 13 ( Supplementary Fig. 3a) , which had lost Prdm3 staining ( Supplementary Fig. 3b ). The control 14 Kras G12D mice had less evidence of tumorigenesis compared with Kras G12D -Prdm3 ΔAcinar mice. 15
Specifically, in Kras G12D -Prdm3 ΔAcinar mice, the ratio of pancreas-to-body weight increased ( Fig.  16 3b); the number of Cpa1 + acinar cells decreased dramatically and CK19 + duct-like cells increased 17 ( Fig. 3c) ; a higher percentage of the pancreas was replaced by acidic mucin content indicated by 18 Alcian Blue staining (Fig. 3c) ; and the number of high-grade PanIN significantly elevated ( Fig.  19 3e). Moreover, we consistently observed tumor budding associated with many high-grade 20 neoplastic lesions in Kras G12D -Prdm3 ΔAcinar mice at 21 days post-cerulein injection (Fig. 3d) . 21
Tumor budding is a strong prognostic indicator of aggressive tumor behavior, which is defined 22
as the presence of single cells or clusters of less than five tumor cells scattered in the stroma 18 . In 23 contrast to Kras G12D -Prdm3 ΔAcinar mice, tumor budding was rarely observed in Kras G12D mice, 1 suggesting that loss of Prdm3 accelerates pancreatic cancer formation in Kras G12D -expressing 2 mice. Together, our data suggest that progression of low-grade precursor lesions to high-grade 3
PanIN is more rapid in the absence of Prdm3. 4 5
Loss of Prdm3 in acinar cells enhances pancreatitis 6
Given that inflammation promotes cancer formation and Prdm3 was significantly increased 7 in humans with pancreatitis, we further determined whether Prdm3 modulated the inflammatory 8 response of the pancreas in Ptf1a CreER ;Prdm3 flox/flox mice. Mice injected with tamoxifen, but 9 lacking the Prdm3 flox allele, were used as controls (Ptf1a CreER mice). Seven days after tamoxifen 10 administration, the Prdm3 protein was absent in more than 80% of acinar cells in Prdm3 ΔAcinar 11 mice, indicating efficient and specific deletion of Prdm3 ( Supplementary Fig. 4a ). Acute 12 pancreatitis was induced with intraperitoneal injection of cerulein, as described previously 19 (Fig.  13   4a) . Specifically, 7 days after the last tamoxifen injection, Prdm3 ΔAcinar and control (Ptf1a CreER ) 14 mice were injected with 50 μ g/kg cerulein at hourly intervals for 8 hours. Histological 15 assessment of pancreata from mice 3 hours after the last cerulein injection demonstrated 16 exaggerated interstitial edema, cytoplasmic vacuolization and immune cell infiltration in 17
Prdm3 ΔAcinar mice compared with control mice (Fig. 4b) . Consistently, examination of neutrophil 18 infiltration demonstrated a substantial increase in the number of Ly6B.2 + cells in cerulein-treated 19
Prdm3 ΔAcinar pancreata (Fig. 4b) . Elevated blood amylase levels are an indicator of pancreatitis. 20
Consistent with the neutrophil infiltration in the pancreas, we observed significantly higher 21 levels of serum amylase in Prdm3 ΔAcinar mice compared to controls (Fig. 4c ). To determine 22 whether the expression of inflammatory cytokines is increased, we harvested RNA from 23 pancreata of Prdm3 ΔAcinar and control mice to performe quantitative RT-PCR. As expected, 1 expression of inflammatory cytokines, including Il-6, Cxcl-1, Cxcl-10, Ccl2, and Ccl20, 2 increased significantly in Prdm3-deleted compared to control pancreata ( Supplementary Fig.  3 4b). We further examined pancreata harvested from Prdm3 ΔAcinar and control mice 48 hours after 4 two series of 8-hourly injection of cerulein (Fig. 4a ). Characterization by immunohistochemistry 5 for the ductal marker CK19 confirmed that acini undergoing acinar-to-ductal metaplasia 6 increased dramatically in Prdm3 ΔAcinar mice (Fig. 4d) . These results illustrate that acinar-cell-7 specific ablation of Prdm3 augments the severity of pancreatitis, suggesting a specific role of 8
Prdm3 as a modulator of inflammatory response in the pancreas. 9
Injured acinar cells initiate inflammatory responses by releasing proinflammatory cytokines, 10 digestive enzymes, and nuclear damage-associated molecular patterns molecules, which attract 11 and activate immune cell to exacerbate tissue injury 20, 21 . It has been demonstrated that pancreatic 12 acinar cells undergo necrosis when exposed to supraphysiological cerulein in vitro 22 . To 13 investigate whether loss of Prdm3 in acinar cells can enhance the activation of inflammatory 14 cells upon cerulein treatment, we exposed the murine macrophage cells, Raw246.7, to the 15 conditioned media from Prdm3 ΔAcinar or Ptf1a CreER control acini treated with cerulein ( Fig. 4e) . 16
Briefly, acinar cells were isolated from a cohort of Prdm3 ΔAcinar and control mice. Isolated 17 primary acinar cells were allowed to recover in oxygenated medium for 2 hours and 18 subsequently cultured in the presence of 10 nM cerulein for 6 hours. Raw246.7 macrophage cells 19 were incubated in this acinar cell conditioned media for 16 hours. Activation of macrophages 20 was determined by the expression of inflammatory cytokines. We found that the relative 21 expression of inflammatory cytokines Tnf-α and Il-1β was significantly higher in Raw246.7 22 incubated with Prdm3 ΔAcinar conditioned media ( Fig. 4e ), suggesting that more proinflammatory 23 factors were released from Prdm3-deficient cells than controls to stimulate macrophage 1 activation. These results support our findings that Prdm3 ΔAcinar mice are more susceptible to 2 cerulein-induced injury in part by contributing to increased immune cells activation. 3 4
Loss of Prdm3 activates inflammatory response and Hif-1 signaling pathways 5
To further examine the effect of Prdm3 deletion on acinar cell homeostasis, we 6 performed transcriptome analyses of primary acinar cells isolated from Prdm3 ΔAcinar and control 7 mice. Ptf1a CreER ;Prdm3 flox/flox and control Ptf1a CreER mice were injected with four doses of 8 tamoxifen at 4 to 5 weeks of age to induce recombination prior to acini isolation. One week after 9 the last tamoxifen injection, primary acinar cells were isolated as described previously 23 and then 10 allowed to recover in oxygenated medium for 2 hours. Total RNA was extracted from fresh 11 isolated acini and subjected to RNA-seq analysis. The extent of Prdm3 deletion was confirmed 12 in Prdm3 ΔAcinar pancreata ( Supplementary Fig. 5a ). Analysis of RNA-seq data sets was 13 performed by DESeq2. Setting a p-value threshold of 0.05, we identified 1483 genes that were 14 significantly differential expressed (log 2 |Fold change| > 1) in Prdm3-deficient acini compared 15 with control ( Supplementary Table 2 ). Moreover, 1073 out of 1483 differentially expressed 16 genes (DEGs) were upregulated, while only 410 of them were downregulated ( Fig. 5a) . We 17 found that the expression of many adhesion molecules involved in the inflammatory response, 18 such as the TNF receptor superfamily Tnfrsf21 and Tnfrsf23, interleukin receptors Il18r1 and 19
Il1r2, and toll like receptors Tlr1, Tlr2 and Tlr3 were significantly altered in Prdm3-deficient 20 cells. Gene Set Enrichment Analysis (GSEA) further demonstrated that genes involved in 21 inflammatory response and regulation of NF-κB signaling were significantly enriched in Prdm3-deficient acinar cells (Fig. 5b) . This suggests that loss of Prdm3 changes cellular homeostasis 1 and favors acinar cells toward a proinflammatory state. 2
To further identify additional biological pathways that were activated upon Prdm3 3 deletion, we performed functional annotation on the 1703 upregulated genes with KEGG and 4
Hallmark data sets. Loss of Prdm3 significantly affected over 30 pathways (Supplementary 5
Table 3) including the Hif-1 signaling pathways (Fig. 5c) . Intriguingly, recent studies 6 demonstrated that mice with acinar cell-specific deletion of Hif1α were less susceptible to 7 cerulein-induced pancreatitis 24 . As our transcriptome analysis revealed a significant elevation of 8
Hif1a in Prdm3-deficient cells, we compared the protein level of Hif1a in control and 9
Prdm3 ΔAcinar pancreata. We confirmed that the expression level of Hif1a was significantly 10 upregulated in Prdm3-depleted pancreatic tissue by immunoblotting and immunohistochemical 11 staining ( Supplementary Fig. 5b-5c In the present study, we investigated the role of Prdm3 in pancreatitis and pancreatic 18 tumorigenesis using mouse models to indelibly delete Prdm3 in adult acinar cells. We 19 demonstrated that PRDM3 was substantially upregulated in pancreatic acinar cells of patients 20 with pancreatitis, as well as well-differentiated PDAC, but not poorly differentiated PDAC. 21
Interestingly, our clinical relevance analysis suggests a prognostic relevance of PRDM3 22 underexpression in PDAC patients with surgical resection. Consistent herewith, we further 23 demonstrated that loss of Prdm3 not only increased the severity of cerulein-induced pancreatitis, 1 but also accelerated cellular atypia and tumorigenic potential in the pancreas, as Prdm3-deficient 2 mice undergo robust formation of precursor lesions in the presence of oncogenic Kras. These 3 findings implicate a potentially protective mechanism of Prdm3 in pancreatic exocrine cells, 4 which is different from the pro-tumor role of PRDM3 in several aggressive forms of cancer 5 including colon, breast and ovarian cancer [26] [27] [28] . A number of alternatively spliced variants, 6
including the long and short forms of PRDM3, are expressed in pancreatic cancer cells 14 . Our 7 studies cannot distinguish which forms of PRDM3 are necessary for its anti-tumor effect in 8 acinar cells, therefore, more work will be needed to examine the effects of different PRDM3 9 isoforms on pancreatitis and pancreatic cancer initiation. 10
Previous studies demonstrated that Prdm3 promotes proliferation and migration in 11 established pancreatic cancer cell lines 14 . However, when Prdm3 was knocked out in pancreatic 12 acinar cells, we observed that Prdm3 depletion potentiated pancreatic cancer initiation and 13 progression to high-grade lesions including ductal carcinoma in situ, suggesting that Prdm3 plays 14 a suppressive role in acinar-to-ductal transformation. At a molecular level, we found that over 70% 15 of the differentially expressed genes between normal and Prdm3-deficient acinar cells were 16 upregulated in Prdm3 ΔAcinar mice, which is consistent with previous studies demonstrating that 17
Prdm3 acts as a transcriptional repressor through interaction with a variety of co-repressors, such 18 as CtBP, histone methyltransferase SUV39H1 and deacetylase HDAC1/2 10 . We therefore 19 postulate that increased Prdm3 expression in transformed ductal-like cells plays an inhibitory 20 role in pancreatic tumorigenesis through the ability of Prdm3 to suppress a series of signaling 21 cascades important for malignant transformation in exocrine pancreas. 1 cerulein-induced injury. Loss of Prdm3 enhanced ADM formation and immune cell activation 2 after cerulein treatment. Our transcriptome analysis suggests that deletion of Prdm3 in adult 3 pancreatic acini induced significant changes in expression for genes involved in inflammatory 4 response and regulation of NF-κB signaling which is constitutively activated in pancreatitis and 5 pancreatic cancer 29 . Several studies have suggested that inflammation leads to an increase of Ras 6 activity and amplifying oncogenic Ras signaling is necessary for pancreatic cancer progression 30-7 32 . Activation of Kras alone in mice leads to PDAC formation at a low frequency and takes over 8 one year 33 . In contrast, when pancreatitis was induced in Kras G12D mice, tumorigenesis occurred 9 within a few months 8, 34 suggesting that precancerous lesions can arise from acinar cells through 10 a process dramatically hastened by inflammation 35 . In this study, we demonstrated that loss of 11
Prdm3 accelerated Kras G12D -induced PanIN initiation and promoted rapid progression of pre-12 neoplastic lesions to invasive lesions. Given that activation of inflammatory response elevates 13 constitutive Ras activity, we propose that, loss of Prdm3 upregulates the expression of genes 14 involved in inflammatory response in pancreatic acinar cells, which modulates acinar cell 15 homeostasis to increase sensitivity of acinar cells to inflammatory stimuli and promote 16 widespread formation of precancerous lesions among Kras mutated acinar cells. 17
Additionally, we found that hypoxia inducible factor Hif1a was significantly upregulated 18 in Prdm3-deficent acinar cells at both mRNA and protein levels. Our findings are consistent with 19 the previous study in which knockdown of Prdm3 upregulated Hif1a in DA-1 and NFS-60 20 leukemic cells 25 . It has also recently been established that HIF-1 signaling plays important roles 21 in both pancreatitis and pancreatic cancer. Hif1a is overexpressed in chronic pancreatitis 36 and its 22 high expression is associated with poor prognosis in PDAC 37, 38 . Acinar-cell-specific deletion of 23
Hif1a prevented intrapancreatic coagulation of fibrinogen and protected mice from cerulein-1 induced acute pancreatitis 24 , suggesting a functional role of Hif1a in the development of 2 pancreatitis. Given that loss of Prdm3 exaggerated inflammation, we speculate that dysregulation 3 of Hif1a expression might contribute to the dramatic effects of Prdm3 depletion on pancreatitis. 4
Taken together, our data demonstrated that loss of Prdm3 not only increased the severity 5 of cerulein-induced pancreatitis, but also accelerated cellular atypia and tumorigenic potential in 6 the pancreas, as Prdm3-deficient mice undergo robust formation of precursor lesions in the 7 presence of oncogenic Kras. We uncovered a previously unappreciated role for Prdm3 as a 8 suppressor of both pancreatitis and pancreatic tumorigenesis presumably through regulating 9 inflammatory and Hif-1 signaling pathways in the pancreatic acinar cells. To induce acute pancreatitis, experimental mice were fasted overnight before administration of 6 cerulein as described previously 4 . Cerulein (American Peptide, Sunnyvale, CA) was dissolved in 7 saline and administrated intraperitoneally at 50 μg/kg body weight hourly for 8 hours. Mice were 8 sacrificed after 3 hours recovery. Alternatively, mice were injected with cerulein (50 μg/kg body 9 weight) at hourly intervals for 8 hours per day for two consecutive days and sacrificed at 48 10 hours after the last injection. To accelerate tumorigenesis, mice were given hourly injections of 11 cerulein (50 μg/kg body weight) for 6 hours per day on alternating days separated by 24 hours 12 and sacrificed after 21 days. 13 14
Histology and immunohistochemical analyses 15
Paraffin-embedded sections were prepared and subjected to hematoxylin, eosin Y, Alcain Blue 16 or immunohistochemical staining. H&E staining and IHC followed our established procedures 5 , 17
including antigen retrieval with citrate buffer (pH 6.0) prior to staining paraffin sections. For 18 Alcian Blue staining, paraffin sections were incubated in 3% acetic acid for 3 minutes, followed 19 by staining in 1% Alcian Blue staining solution for 30 minutes, and subsequently in Nuclear Fast 20
Red for 5 minutes. All slides were scanned with a 20× objective using a 2D glass slide digital 21 scanner (Leica Biosystems, Vista, CA) and examined at high magnification using the Aperio 
RNA isolation and quantitative real-time PCR 2
Mice were sacrificed with CO 2 asphyxiation followed by cervical dislocation. Pancreata were 3 immediately harvested and cut into small pieces in RNALater (Qiagen, Redwood, CA). To detect 4 mRNAs, twenty mg of tissue was homogenized in 1 ml of Trizol using a T 10 basic ULTRA-5 TURRAX® homogenizer. RNA was extracted from Trizol according to the manufacturer's 6 instructions (Thermo Fisher Scientific, Waltham, MA) and subsequently subjected to reverse 7 transcription using PrimeScript™ RT reagent Kit (TaKara Bio, Mountain View, CA). 8
Quantitative real-time PCR was performed with Premix Ex Taq (TaKara Bio) on CFX96 qPCR 9 system (BioRad Laboratories). Results were normalized to Gapdh for mRNA detection. The 10 quantitative real-time PCR primer sequences are list in Supplementary Table 5.  11 12
Western blotting 13
Pancreata were harvested and snap frozen in liquid nitrogen. The frozen tissue was homogenized 14 in lysis buffer containing 20 mM Tris-HCl (pH 7.5). 150 mM NaCl, 1 mM Na 2 EDTA, 2mM 15 Na 2 VO 4 , 1% Triton X-100, 5mM 4-nitrophenyl phosphate, 0.5% sodium deoxylcholate, 1mM 16 phenylmethanesulfonylfluoride, protease inhibitor cocktail (Sigma). Twenty μg of protein was 17 separated on a 10% sodium dodecyl sulfate-polyacrylamide gel, transferred onto a 18 polyvinylidene difluoride membrane, and probed with antibodies. The membranes were 19 visualized using ECL™ Western Blotting Detection System (GE Healthcare) and ChemiDoc™ 20
Imaging Systems (BioRad Laboratories). 21 1 was separated from red blood cells by centrifugation at 2500 g for 15 min. The top layer which 2 contained serum was transferred to a new tube for further analysis. Amylase activity was 3 measured using the Amylase Colorimetric Assay Kit following manufacturer's instructions 4 (Sigma). 5 6
Isolation of primary acinar cells 7
Primary acinar cells were isolated as described in detail previously 23 with a small modification. 8
In brief, pancreas was harvested and transferred into ice-cold Hank's balanced salt solution 9 (HBSS). Lymph nodes, fat and mesenteric tissues were carefully removed. Pancreas was minced 10 into 2-to 3-mm pieces and digested with 0.2 mg/ml collagenase P (Roche) at 37 ° C for 10-12 11 minutes. Cell clusters were washed 3 times with ice-cold HBSS containing 5% FBS and filtered 12 reads with low quality were removed using Trim Galore (version 0.4.4) prior to analysis of the 16 data. All the trimmed reads were mapped to reference mouse genome (mm10, GRCm38) by 17 using STAR (version 020201), and the mapped counts were extracted using feature count from 18 Subread package (version 1.5.3). Subsequently, read count data containing 49,492 quantified 19 transcripts with raw reads was preprocessed by filtering out genes with zero read count across 20 different samples, and 20,069 genes remained after filtering. The read count data were 21 normalized by DESeq2, which can be used for downstream differential expression analysis. change > 1 or < -1. P value < 0.05 was considered to be significantly different. Gene set 1 enrichment analysis (GSEA) was performed using Bioconductor R package clusterProfiler 40, 41 . 2
The gene sets implemented were derived from Cancer hallmark, Kyoto Encyclopedia of Genes 3 and Genomes (KEGG) and Gene Ontology (GO), which was collected in the Molecular 4 Signatures Database (MSigDB; version 6.2). Functional enrichment was performed on genes up-5 regulated Prdm3-deficient cells. 6
Statistical Analysis 7
All data are presented as mean ± SD from at least three mice in each experimental group. 8
Statistical analysis of different animal groups was acquired using the t test with GraphPad 9 software. Statistical analyses of patient samples were performed with SPSS software using two-10 sided t test. Kaplan-Meier survival plots were generated using the log-rank test. p value < 0.05 11 was considered statically significant. T  h  e  i  m  a  g  e  c  a  n  n  o  t  b  e  d  i  s  p  l  a  y  e  d  .  Y  o  u  r  c  o  m  p  u  t  e  r  m  a  y  n  o  t  h  a  v  e  e  n  o  u  g  h  m  e  m  o  r  y  t  o  o  p  e  n  t  h  e  i  m  a  g  e  ,  o  r  t  h  e  i  m  a  g  e  m  a  y  h  a  v  e  b  e  e  n  c  o  r  r  u  p  t  e  d  .  R  e  s  t  a  r  t  y  o  u  r  c  o  m  p  u  t  e  r  ,  a  n  d  t  h  e  n  o  p  e  n  t  h  e  f  i  l  e  a  g  a  i  n  .  I  f  t  h  e  r  e  d  x  s  t  i  l  l  a  p  p  e  a  r  s  ,  y  o  u  m  a  y  h  a  v  e  t  o  d  e  l  e  t  e  t  h  e  i  m  a  g  e  a  n  d  t  h  e  n  i  n  s  e  r  t  i  t  a  g  a  i n .
Table 1. Association between expression levels of PRDM3 and clinical relevance in patients 1
with PDAC (n=94) 2 1 All PDAC patients received surgical resection without preoperative chemotherapy; median 3 follow-up was 12.07 months after surgical resection; median survival time for patients deceased 4 was 8.03 months; median follow-up for patients alive was 26.37 months. 5 2 The tumor-node-metastasis (TNM) stages were determined according to the 7th edition TNM 6 classification of the American Joint Committee on Cancer. 7 3 p-values were based on t-test (two-sided). p < 0.05 was considered as statistically significant. 8 Il-6 Rv CCAGAAGACCAGAGGAAA
Cxcl-1 Fw CTGGGATTCACCTCAAGAACATC 117bp
Cxcl-1 Rv CAGGGTCAAGGCAAGCCTC
Cxcl-10 Fw GCACGAACTTAACCACCATCTTCC 179bp
Cxcl-10 Rv CTACCCATTGATACATACTTGATGACAC Ccl2 Fw GGCTCAGCCAGATGCAGTTA 185bp
Ccl2 Rv GGACCCATTCCTTCTTGGGG Ccl20 Fw CCTGATTTGTGTCCCAGTGGACTT 188bp
Ccl20 Rv TTAATCCTTCCACTAAGCGCCC
Il-1β Fw TGACGGACCCCAAAAGAT 122bp
Il-1β Rv GTGATACTGCCTGCCTGA
Tnf-α Fw CCAAAGGGATGAGAAGTTCC 133bp
Tnf-α Rv CTCCACTTGGTGGTTTGCTA
Gapdh Fw GTGTTCCTACCCCCAATGTGT 248bp
Gapdh Rv ATTGTCATACCAGGAAATGAGCTT
